Skip to search.
 FTSE 100 Down 2.71%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
1.50 Down 0.07(4.46%) 8 Feb 21:00
|After Hours: : 1.50 Up 0.00 (0.02%) 21:59
Prev Close:1.57
Open:1.53
Bid:1.35 x 200
Ask:1.75 x 4000
1y Target Est:5.50
Beta:0.984398
Earnings Date:29 Feb - 4 Mar (Est.)
Day's Range:1.43 - 1.59
52wk Range:1.30 - 5.12
Volume:2,889,437
Avg Vol (3m):2,889,040
Market Cap:363.82m
P/E (ttm):N/A
EPS (ttm):-0.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNADown 4.46%363.82m
OREXDown 5.43%253.07m
GSKDown 3.16%95.52b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.58
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.45
Quarterly EPS Est (Dec-15) :-0.13
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.18

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback